Advertisement

Topics

Novo Nordisk cuts 1300 jobs in the midst of Trump's pricing pressures and depreciation of US dollar

06:51 EDT 2 Nov 2018 | Pharmafile

Danish multinational Novo Nordisk has said that they will have cut 1,300 employees by the end of 2018. The decision has come partly in response to the Trump administration’s efforts to reduce the price of drugs, according to Novo Nordisk CEO Lars Fruergaard Jørgensen.  

The Novo Nordisk chief commented: “This is part of preparing for that [the Trump administration’s pricing plan] but it is as much about investing in the business, so we don’t have any plans about doing any new measures for 2019.”

read more

Original Article: Novo Nordisk cuts 1300 jobs in the midst of Trump's pricing pressures and depreciation of US dollar

NEXT ARTICLE

More From BioPortfolio on "Novo Nordisk cuts 1300 jobs in the midst of Trump's pricing pressures and depreciation of US dollar"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...